NCT02640547View on ClinicalTrials.gov

Real World Evidence of the Effectiveness of Paritaprevir/Ritonavir, Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C

CompletedOBSERVATIONAL
Enrollment

394

Participants

Timeline

Start Date

November 26, 2015

Primary Completion Date

March 29, 2017

Study Completion Date

March 29, 2017

Conditions
Chronic Hepatitis C
Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
collaborator

IST GmbH, Germany

INDUSTRY

lead

AbbVie

INDUSTRY